twitter

Thursday, 17 September 2015

Natural products—friends or foes?

Volume 236, Issue 3, 5 August 2015, Pages 154–167


Highlights

Food supplements may change the pharmacokinetic profile of drugs.
Food supplements may change the efficacy of drugs.
Food and food supplements might induce toxic outcomes in combination with drugs.

Abstract

A trend in the general population has been observed in recent years regarding the orientation toward preventive measures in health; in this context the increased interest from the users and researchers concerning the active effect of food supplements on the health state and on longevity, is noticeable. All over the world, the consumption of natural foods and of vegetal supplements has increased spectacularly over the last 5–10 years. The decreased prevalence of cardio-vascular diseases associated with Mediterranean diet, as well as the French paradox convinced researchers to scientifically document the beneficial outcomes pointed out by traditional use of plants, and to try to develop supplements that would have the same positive effects as these noticed for diet components.
The intense research dedicated to this topic revealed the fact that food supplements are linked to some problematic aspects, such as toxicological side effects when associated with classical synthetic drugs. The food supplement–drug interactions are submitted to complex issues regarding pharmacokinetic interactions leading to changes in absorption, distribution, metabolism and excretion processes with direct impact on effect and toxicological potential.
The present review based on recent literature aims at discussing the food–drug interactions with direct impact on efficacy and toxicity of drugs.

Abbreviations

  • ADME, absorption, distribution, metabolism and excretion;
  • ROS, reactive oxygen species;
  • MDA, malondialdehyde;
  • OATP, organic anion transporting polypeptide;
  • QQ, quercetin–quinone;
  • GSH, glutathione;
  • RLE, rat lung epithelial cells;
  • LDH, lactate dehydrogenase;
  • ABC, ATP binding cassette;
  • P-gp, P-glycoprotein;
  • MRP 2, multidrug resistance- associated protein 2;
  • TMD, transmembrane domain;
  • NBD, nucleotide-binding domain;
  • BCRP, breast cancer resistance protein;
  • SGLT1, Na+- dependent Na1/glucose co-transporter 1;
  • HCC, hepatocellular carcinoma cells;
  • UGT, UDP-glucuronyltransferase;
  • SULT, sulfotransferase

Keywords

  • Food supplements;
  • Diet components;
  • Food–drug interactions;
  • Toxic outcomes
Corresponding author. Tel.: +40 213111152; fax. +40 213111152.